Oncology Pharma (CE) Aktie - ONPH

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Current Price

0,000001

Gebot

0,00

Fragen

0,00

Volumen

2.000

0,00 Tagesbereich 0,00

0,000001 52-Wochen-Bereich 0,1789

Handelsende

0,000001

Handelsbeginn

Letzte Trade

2000

1.0E-6

(formt)

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

11.775

Finanzvolumen

VWAP

Oncology Pharma Conducting Interviews and Presentations with Investors to Pursue Next Steps to Forward The Development Process of Nanoemulsion Drug Delivery System

Oncology Pharma Conducting Interviews and Presentations with Investors to Pursue Next Steps to Forward The Development Process of Nanoemulsion...

Oncology Pharma Conducting All The Preparations to Take Steps to Forward The Development Process of Nanoemulsion Drug Delivery System

Oncology Pharma Conducting All The Preparations to Take Steps to Forward The Development Process of Nanoemulsion Drug Delivery...

Oncology Pharma Announces: Initial Feasibility Study of the Nanoemulsion Drug Delivery System is Complete and Results Have Met the Threshold for Moving Forward To the Next Steps of Development

Oncology Pharma Announces: Initial Feasibility Study of the Nanoemulsion Drug Delivery System is Complete and Results Have Met the Threshold for...

Oncology Pharma Advances Progress on Multiple Fronts Including Advanced Attention to Connect2Trials' Commercial Development

Oncology Pharma Advances Progress on Multiple Fronts Including Advanced Attention to Connect2Trials' Commercial Development ...

Oncology Pharma Completes Feasibility Phase of its Licensed Nanoemulsion Drug Delivery System to Treat Cancer

Oncology Pharma Completes Feasibility Phase of its Licensed Nanoemulsion Drug Delivery System to Treat Cancer San Francisco, CA -- April 13, 2022...

Oncology Pharma Reports on Progress with Ribera Solutions

SAN FRANCISCO, CA -- March 2, 2022 -- InvestorsHub NewsWire -- Oncology Pharma Inc. (OTC PINK: ONPH) - Oncology Pharma, Inc. ("The Company") is...

Oncology Pharma Releases Further Feasibility Studies, Data and Capacities

SAN FRANCISCO, CA -- February 23, 2022 -- InvestorsHub NewsWire -- Oncology Pharma Inc. (OTC PINK: ONPH) - Oncology Pharma, Inc. ("The Company...

Oncology Pharma Expands on Feasibility Studies and Data

SAN FRANCISCO, CA -- February 17, 2022 -- InvestorsHub NewsWire -- Oncology Pharma Inc. (OTC PINK:ONPH) - Oncology Pharma, Inc...

Oncology Pharma, Inc. and Regen BioPharma, Inc. Announce Intent to Jointly Fast Track Development of Modified mRNA anti-Cancer Vaccine

San Francisco, CA -- February 14, 2022 -- InvestorsHub NewsWire -- Oncology Pharma, Inc. ("The Company") (OTC PINK:ONPH) and Regen...

Oncology Pharma Gives Update on Technology, Formulation and Data Creation

SAN FRANCISCO, CA – February 8, 2022 – InvestorsHub NewsWire -- Oncology Pharma Inc. (OTC PINK: ONPH) - Oncology Pharma, Inc...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	1.0E-6	1.0E-6	1.0E-6	298	1.0E-6	CS
4	-9.9E-5	-99	0.0001	0.0001	1.0E-6	2456	7.582E-5	CS
12	0	0	1.0E-6	0.001	1.0E-6	11775	9.484E-5	CS
26	0	0	1.0E-6	0.03	1.0E-6	9797	0.00029059	CS
52	0	0	1.0E-6	0.1789	1.0E-6	6625	0.00025742	CS
156	-5.059999	-99.9999802372	5.06	7.23	1.0E-6	48530	1.40177448	CS
260	-0.029999	-99.9966666667	0.03	50	1.0E-6	134130	6.48979647	CS

ONPH - Frequently Asked Questions (FAQ)

What is the current Oncology Pharma (CE) share price?

The current share price of Oncology Pharma (CE) is US$ 0,000001

What is the 1 year trading range for Oncology Pharma (CE) share price?

Oncology Pharma (CE) has traded in the range of US$ 0,000001 to US$ 0,1789 during the past year

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
SMKGSmart Card Marketing Systems Inc (PK)	US$ 0,0019 (189.900,00%)	9,86k
TVOGTurner Valley Oil and Gas Inc (CE)	US$ 0,0005 (49.900,00%)	247,03k
AASZDAtlantic Sapphire AS (QB)	US$ 1,09 (15.471,43%)	731
TIOGTingo Group Inc (CE)	US$ 0,015 (14.900,00%)	10,34k
FPWMCharlestowne Premium Beverages Inc (CE)	US$ 0,0001 (9.900,00%)	450
ZHCLFZenith Capital Corporation (CE)	US$ 0,0001 (-99,90%)	150
ELYSElys BMG Group Inc (CE)	US$ 0,000001 (-99,75%)	327
GRMCGoldrich Mining Company (CE)	US$ 0,000001 (-99,67%)	500
THMOThermoGenesis Holdings Inc (CE)	US$ 0,000001 (-99,67%)	1,16k
ELIQQElectriq Power Holdings Inc (CE)	US$ 0,0015 (-99,25%)	100
AFFUAffluence Corp (PK)	US$ 0,00025 (-37,50%)	230,6M
DPUIDiscount Print USA Inc (PK)	US$ 0,0002 (0,00%)	188,75M
PHILPHI Group Inc (PK)	US$ 0,0002 (0,00%)	161,7M
CBDDCBD of Denver Inc (PK)	US$ 0,0002 (0,00%)	150,4M
HMBLHUMBL Inc (PK)	US$ 0,0005 (0,00%)	143,28M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Oncology Pharma Inc (CE) (ONPH)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

ONPH Neueste Nachrichten

Oncology Pharma Conducting Interviews and Presentations with Investors to Pursue Next Steps to Forward The Development Process of Nanoemulsion Drug Delivery System

Oncology Pharma Conducting All The Preparations to Take Steps to Forward The Development Process of Nanoemulsion Drug Delivery System

Oncology Pharma Announces: Initial Feasibility Study of the Nanoemulsion Drug Delivery System is Complete and Results Have Met the Threshold for Moving Forward To the Next Steps of Development

Oncology Pharma Advances Progress on Multiple Fronts Including Advanced Attention to Connect2Trials' Commercial Development

Oncology Pharma Completes Feasibility Phase of its Licensed Nanoemulsion Drug Delivery System to Treat Cancer

Oncology Pharma Reports on Progress with Ribera Solutions

Oncology Pharma Releases Further Feasibility Studies, Data and Capacities

Oncology Pharma Expands on Feasibility Studies and Data

Oncology Pharma, Inc. and Regen BioPharma, Inc. Announce Intent to Jointly Fast Track Development of Modified mRNA anti-Cancer Vaccine

Oncology Pharma Gives Update on Technology, Formulation and Data Creation

ONPH - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Oncology Pharma Inc (CE) (ONPH) Börsenkurse

Oncology Pharma Inc (CE) (ONPH)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

ONPH Neueste Nachrichten

Oncology Pharma Conducting Interviews and Presentations with Investors to Pursue Next Steps to Forward The Development Process of Nanoemulsion Drug Delivery System

Oncology Pharma Conducting All The Preparations to Take Steps to Forward The Development Process of Nanoemulsion Drug Delivery System

Oncology Pharma Announces: Initial Feasibility Study of the Nanoemulsion Drug Delivery System is Complete and Results Have Met the Threshold for Moving Forward To the Next Steps of Development

Oncology Pharma Advances Progress on Multiple Fronts Including Advanced Attention to Connect2Trials' Commercial Development

Oncology Pharma Completes Feasibility Phase of its Licensed Nanoemulsion Drug Delivery System to Treat Cancer

Oncology Pharma Reports on Progress with Ribera Solutions

Oncology Pharma Releases Further Feasibility Studies, Data and Capacities

Oncology Pharma Expands on Feasibility Studies and Data

Oncology Pharma, Inc. and Regen BioPharma, Inc. Announce Intent to Jointly Fast Track Development of Modified mRNA anti-Cancer Vaccine

Oncology Pharma Gives Update on Technology, Formulation and Data Creation

ONPH - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen